MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WEBER, M.
Right arrow Articles by CHANGEUX, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WEBER, M.
Right arrow Articles by CHANGEUX, J.-P.

Molecular Pharmacology, Vol 10, 15-34, Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics

Binding of Naja nigricollis [3H]agr-Toxin to Membrane Fragments from Electrophorus and Torpedo Electric Organs

II. Effect of Cholinergic Agonists and Antagonists on the Binding of the Tritiated agr-Neurotoxin

MICHEL WEBER 1 and JEAN-PIERRE CHANGEUX 1

1 Neurobiologie Moléculaire, Institut Pasteur, Paris XVe, France

The effects of nicotinic effectors on the kinetics of association and dissociation and on the binding at equilibrium of a tritiated agr-neurotoxin from Naja nigricollis with membrane fragments purified from Electrophorus and Torpedo electric organs are studied. Increasing concentrations of nicotinic agonists and antagonists decrease the initial rate of [3H]agr-toxin binding to membrane fragments from both species. This rate becomes negligible at high concentrations of effectors. The "protection curves" obtained are compared with the binding curves of radioactive effectors to the same membrane fragments. In the case of Torpedo membrane fragments, the binding curve of [3H]-acetylcholine (in the presence of O,O-diethyl S-(beta-diethylamino)ethyl phosphorothiolate) is slightly sigmoid (nH = 1.3); half-saturation occurs at 8 nM acetylcholine. [3H]-Decamethonium binds to one class of sites with KD = 0.8 µM, and possibly to another class with lower affinity. The binding of both acetylcholine and decamethonium is competitively inhibited by d-tubocurarine (KD = 0.2 µM) and completely displaced by agr-toxin. The numbers of decamethonium and acetylcholine binding sites on Torpedo membrane fragments are very close to the number of [3H]agr-toxin binding sites. The binding curves of decamethonium and acetylcholine can be superimposed on the "protection curves" of these two agonists against [3H]agr-toxin binding. The data are in terpreted on the basis of a mutual exclusion of cholinergic effectors and agr-toxin from a common site, which is identified as the nicotinic receptor site. Comparison of our protection data with the binding data of Kasai and Changeux [(1971) J. Membr. Biol., 6, 1-80] shows that the same result holds in the case of Electrophorus membrane fragments. The dissociation constants of a large spectrum of cholinergic effectors were determined by following the protection against [3H]agr-toxin. The pharmacological properties of the receptors from Electrophorus and Torpedo appear different. In the case of Electrophorus, the dissociation constants for all the agonists and antagonists coincide with the "apparent dissociation constants" measured in vivo on the electroplax. At equilibrium decamethonium and d-tubocurarine displace [3H]agr-toxin from Electrophorus membrane fragments; the data are in given domains of concentrations, compatible with the hypothesis of a mutual exclusion of agr-toxin and cholinergic effectors from the same binding site. However, higher concentrations of both ligands enhance the rate of dissociation of [3H]]agr-toxin from its membrane site.

Note:
ACKNOWLEDGMENTS We thank Professor P. Boquet for purification and a generous gift of pure agr-toxin; Drs. A. Menez, J.-L. Morgat and P. Fromageot for its tritiation; Professor P. G. Waser for the gift of muscarone; and the Laboratoire Roger Bellon for the gift of dimethisoquin and prilocaine. We thank Drs. R. L. Baldwin, H. Buc, J. B. Cohen, G. L. Hazelbauer, H. Lester, J. C. Meunier, R. W. Olsen, and H. Sealock for helpful criticism and suggestions and aid in the preparation of the manuscript. We thank Dr. J. Patrick for the privileged communication of a manuscript in publication.

Submitted on June 11, 1973




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Sanders and E. Hawrot
A Novel Pharmatope Tag Inserted into the {beta}4 Subunit Confers Allosteric Modulation to Neuronal Nicotinic Receptors
J. Biol. Chem., December 3, 2004; 279(49): 51460 - 51465.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. E. Hibbs, T. T. Talley, and P. Taylor
Acrylodan-conjugated Cysteine Side Chains Reveal Conformational State and Ligand Site Locations of the Acetylcholine-binding Protein
J. Biol. Chem., July 2, 2004; 279(27): 28483 - 28491.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Osaka, N. Sugiyama, and P. Taylor
Distinctions in Agonist and Antagonist Specificity Conferred by Anionic Residues of the Nicotinic Acetylcholine Receptor
J. Biol. Chem., May 22, 1998; 273(21): 12758 - 12765.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. Raftery, M. Hunkapiller, C. Strader, and L. Hood
Acetylcholine receptor: complex of homologous subunits
Science, June 27, 1980; 208(4451): 1454 - 1456.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
S. Antil-Delbeke, C. Gaillard, T. Tamiya, P.-J. Corringer, J.-P. Changeux, D. Servent, and A. Menez
Molecular Determinants by Which a Long Chain Toxin from Snake Venom Interacts with the Neuronal alpha 7-Nicotinic Acetylcholine Receptor
J. Biol. Chem., September 15, 2000; 275(38): 29594 - 29601.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics